Literature DB >> 20466537

Impact of information about risks and benefits of cancer screening on intended participation.

Thomas V Perneger1, Stéphane Cullati, Laura Schiesari, Agathe Charvet-Bérard.   

Abstract

BACKGROUND: Providing comprehensive information about the risks and benefits of cancer screening is ethically necessary, but information about risks may decrease participation. This study explored the impact of information on intended participation using a randomised factorial design.
METHODS: We conducted a mail survey of 2333 adults living in Geneva, Switzerland. Each participant was given one randomly chosen version of a scenario that described a hypothetical cancer screening test, and was asked whether he or she would accept to undergo screening. The versions varied in terms of the amount of information about risks and benefits.
RESULTS: Respondents who received information about risks associated with screening were more likely to refuse participation (odds ratio 2.6 (95% confidence interval (CI) 2.0-3.5)) than those who received minimal information. In contrast, information about benefits had no impact on intended participation (odds ratio 1.0 (95% CI 0.8-1.2)). The impact of information about risks was significantly stronger in women than in men, in respondents who were in poorer health, who have had a doctor visit in the past 6months, those who have had a cancer screening test in the past 3years, and those who reported a high desire for autonomy in medical decisions.
CONCLUSIONS: Informing potential participants about the risks of screening may reduce participation rates. Enhanced information about the benefits of screening does not counterbalance this effect. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20466537     DOI: 10.1016/j.ejca.2010.04.011

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Public views on participating in newborn screening using genome sequencing.

Authors:  Yvonne Bombard; Fiona A Miller; Robin Z Hayeems; Carolyn Barg; Celine Cressman; June C Carroll; Brenda J Wilson; Julian Little; Denise Avard; Michael Painter-Main; Judith Allanson; Yves Giguere; Pranesh Chakraborty
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

2.  Adult Patients' Perspectives on the Benefits and Harms of Overused Screening Tests: a Qualitative Study.

Authors:  Anne Sutkowi-Hemstreet; Maihan Vu; Russell Harris; Noel T Brewer; Rowena J Dolor; Stacey L Sheridan
Journal:  J Gen Intern Med       Date:  2015-04-14       Impact factor: 5.128

3.  People's willingness to accept overdetection in cancer screening: population survey.

Authors:  Ann Van den Bruel; Caroline Jones; Yaling Yang; Jason Oke; Paul Hewitson
Journal:  BMJ       Date:  2015-03-03

4.  Preparing African American Men to Make Informed Prostate Cancer Screening Decisions: Development and Pilot Testing of an Interactive Online Decision Aid.

Authors:  Jennifer Dacey Allen; Amanda Reich; Adolfo G Cuevas; Keren Ladin
Journal:  JMIR Mhealth Uhealth       Date:  2020-05-05       Impact factor: 4.773

5.  African American Women's Involvement in Promoting Informed Decision-Making for Prostate Cancer Screening Among Their Partners/Spouses.

Authors:  Jennifer D Allen; Ifedayo C Akinyemi; Amanda Reich; Sasha Fleary; Shalini Tendulkar; Nadeerah Lamour
Journal:  Am J Mens Health       Date:  2018-01-04

6.  Intermittent attendance at breast cancer screening.

Authors:  Padraic Fleming; Sinead O'Neill; Miriam Owens; Therese Mooney; Patricia Fitzpatrick
Journal:  J Public Health Res       Date:  2013-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.